Solu Therapeutics is a precision-medicine company developing therapeutics to eliminate cells that drive oncologic, inflammatory, and autoimmune diseases.
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.04.2025 | Series A | $41M | - |
| 01.08.2023 | Seed | $31M | - |
Mentions in press and media 6
| Date | Title | Description |
| 10.04.2025 | Solu Therapeutics: A New Dawn in Cancer Treatment with $41 Million Series A Funding | Solu Therapeutics is on the rise. The Boston-based biotechnology company has just secured $41 million in Series A funding. This financial boost comes from a mix of new and existing investors, including heavyweights like Eli Lilly and The Le... |
| 09.04.2025 | Solu Therapeutics: $41 Million (Series A) Raised For Developing Therapies To Eliminate Disease-Driving Cells | Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, announced the completion of a $41 million Series A financing that included participation ... |
| 09.04.2025 | Solu Therapeutics Closes $41M Series A Financing | Solo Therapeutics, a Boston, MA-based biotechnology company advancing therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, raised $41M in Series A funding.
Backers included participation from five... |
| 01.08.2023 | Solu Therapeutics Raises $31M in Seed Funding | Solu Therapeutics, a Boston, MA-based precision-medicine company developing therapeutics to eliminate disease-driving cells, closed a $31m seed financing.
The round was co-led by Longwood Fund, and Santé Ventures, with participation from DC... |
| - | Solu Therapeutics | “Solu Therapeutics” |
| - | Solu Therapeutics | “Solu Therapeutics – A next-generation precision oncology-focused company” |
Reviews 0
